Hannah Dye
Family · Oxford, MSNPI 1831640911
Payments from drug & device makers
Across 111 payments — averaging $16.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$485
- Astellas Pharma US Inc$275
- Exeltis, USA Inc.$246
- Biogen$174
- Mayne Pharma Commercial LLC$166
- Hologic Sales And Service, LLC$92
- plus $446 from 15 others
What the payments were for
- Food & beverage$1,884100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 44 | $485 |
| Astellas Pharma US Inc | 10 | $275 |
| Exeltis, USA Inc. | 13 | $246 |
| Biogen | 7 | $174 |
| Mayne Pharma Commercial LLC | 10 | $166 |
| Hologic Sales And Service, LLC | 4 | $92 |
| Organon | 4 | $63 |
| Aspira Women's Health Inc | 1 | $55 |
| Novo Nordisk | 1 | $51 |
| Amgen | 3 | $48 |
| Pfizer | 2 | $33 |
| Bayer | 2 | $31 |
| Shield Therapeutics Inc | 2 | $29 |
| Axonics, Inc. | 1 | $24 |
| Merck | 1 | $21 |
| Davol Inc. | 1 | $18 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
| Therapeuticsmd, Inc. | 1 | $15 |
| Evofem Biosciences, Inc. | 1 | $14 |
| Daiichi Sankyo Inc. | 1 | $13 |
| Virtus Pharmaceuticals LLC | 1 | $13 |
How this compares
$1,884 in reported general payments places this provider in the 80th percentile of 3,007 family providers in Mississippi.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 49 | $3,342 |
| PremarinEstrogens, Conjugated | 12 | $2,592 |
| Medroxyprogesterone Acetate | 12 | $319 |
| Alendronate Sodium | 30 | $112 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerPremarin | $33 | $2,59212 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,007 family providers in Mississippi.
Other family in Oxford
- Shannon FryeryOxford$127K
- Penny BurchamOxford$22K
- Anna WiygulOxford$15K
- Erin SmithOxford$13K
- Cinda PerrymanFayette$888K
- Dodie McGeeRaymond$772K
- Gina BurgeJackson$237K
- Christy DavisJackson$208K
- Maranda EversollFlowood$197K
- Dana DelaskiJackson$158K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.